(Q67657200)
Statements
Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype (English)
Weil-Hillman G
G. Weil-Hillman
S. D. Voss
P. Fisch
K. Schell
J. A. Hank
J. A. Sosman
K. Sugamura